Current challenges in primary lateral sclerosis diagnosis

References

• Le Forestier N, Maisonobe T, Piquard A, et al. Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature. Brain. 2001;124(10):1989–1999. doi: 10.1093/brain/124.10.1989
   PubMedGoogle Scholar
• Turner MR, Talbot K. Primary lateral sclerosis: diagnosis and management. Pract Neurol. 2020;20(4):262–269. doi: 10.1136/practneurol-2019-002300
   PubMedGoogle Scholar
• Singer MA, Kojan S, Barohn RJ, et al. Primary lateral sclerosis: clinical and laboratory features in 25 patients. J Clin Neuromuscul Dis. 2005;7(1):1–9. doi: 10.1097/01.cnd.0000176974.61136.45
   PubMedGoogle Scholar
• Statland JM, Barohn RJ, Dimachkie MM, et al. Primary lateral sclerosis. Neurol Clin. 2015;33(4):749–760. doi: 10.1016/j.ncl.2015.07.007
   PubMed Web of Science ®Google Scholar
• Turner MR, Barohn RJ, Corcia P, et al. Primary lateral sclerosis: Consensus diagnostic criteria. J Neurol Neurosurg Psychiatry. 2020;91(4):373–377. doi: 10.1136/jnnp-2019-322541
   PubMed Web of Science ®Google Scholar
• Bruyn RP, Koelman JH, Troost D, et al. Motor neuron disease (amyotrophic lateral sclerosis) arising from longstanding primary lateral sclerosis. J Neurol Neurosurg Psychiatry. 1995;58(6):742–744. doi: 10.1136/jnnp.58.6.742
   PubMed Web of Science ®Google Scholar
• Swash M, Desai J, Misra VP. What is primary lateral sclerosis? J Neurol Sci. 1999;170(1):5–10. doi: 10.1016/S0022-510X(99)00184-7
   PubMed Web of Science ®Google Scholar
• Singer MA, Statland JM, Wolfe GI, et al. Primary lateral sclerosis. Muscle Nerve. 2007;35(3):291–302. doi: 10.1002/mus.20728
   PubMed Web of Science ®Google Scholar
• Barohn RJ, Fink JK, Heiman-Patterson T, et al. The clinical spectrum of primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(sup1):3–10. doi: 10.1080/21678421.2020.1837178
   PubMedGoogle Scholar
• Gordon PH, Cheng B, Katz IB, et al. The natural history of primary lateral sclerosis. Neurology. 2006;66(5):647–653. doi: 10.1212/01.wnl.0000200962.94777.71
   PubMed Web of Science ®Google Scholar
• Almeida V, de Carvalho M, Scotto M, et al. Primary lateral sclerosis: predicting functional outcome. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(2):141–145. doi: 10.3109/17482968.2012.719237
   PubMed Web of Science ®Google Scholar
• Dickson DW, Josephs KA, Amador-Ortiz C. TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol. 2007;114(1):71–79. doi: 10.1007/s00401-007-0234-5
   PubMed Web of Science ®Google Scholar
• Kosaka T, Fu YJ, Shiga A, et al. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration–immunohistochemical and biochemical analyses of TDP-43. Neuropathology. 2012;32(4):373–384. doi: 10.1111/j.1440-1789.2011.01271.x
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA. Neuropathology of primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020;21(sup1):47–51.
   PubMedGoogle Scholar
• Bede P, Pradat PF, Lope J, et al. Primary lateral sclerosis: Clinical, radiological and molecular features. Rev Neurol (Paris). 2022;178(3):196–205. doi: 10.1016/j.neurol.2021.04.008
   PubMed Web of Science ®Google Scholar
• Strong MJ, Gordon PH. Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: discrete entities or spectrum? Amyotroph Lateral Scler Other Motor Neuron Disord. 2005;6(1):8–16.
   PubMed Web of Science ®Google Scholar
• Finegan E, Chipika RH, Li Hi Shing S, et al. The clinical and radiological profile of primary lateral sclerosis: a population-based study. J Neurol. 2019;266(11):2718–2733. doi: 10.1007/s00415-019-09473-z
   PubMed Web of Science ®Google Scholar
• Gallagher JP. Pathologic laughter and crying in als: a search for their origin. Acta Neurol Scand. 1989;80(2):114–117. doi: 10.1111/j.1600-0404.1989.tb03851.x
   PubMed Web of Science ®Google Scholar
• Abrahams S, Goldstein LH, Al-Chalabi A, et al. Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 1997;62(5):464–472. doi: 10.1136/jnnp.62.5.464
   PubMed Web of Science ®Google Scholar
• Tahedl M, Tan EL, Shing SL, et al. Not a benign motor neuron disease: longitudinal imaging captures relentless motor connectome disintegration in primary lateral sclerosis. Eur J Neurol. 2023 May;30(5):1232–45. doi: 10.1111/ene.15725
   PubMed Web of Science ®Google Scholar
• Mills CK, Spiller WG. A case of progressively developing hemiplegia later becoming triplegia resulting from primary degeneration of the pyramidal tracts. J Nerv Ment Dis. 1903;30(7):385–397. doi: 10.1097/00005053-190307000-00001
   Google Scholar
• Jaiser SR, Mitra D, Williams TL, et al. Mills’ syndrome revisited. J Neurol. 2019 Mar 1;266(3):667–679. doi: 10.1007/s00415-019-09186-3
   PubMed Web of Science ®Google Scholar
• Proudfoot M, Menke RA, Sharma R, et al. Eye-tracking in amyotrophic lateral sclerosis: a longitudinal study of saccadic and cognitive tasks. Amyotroph Lateral Scler Frontotemporal Degener. 2016 Feb 17;17(1–2):101–11. doi: 10.3109/21678421.2015.1054292
   PubMed Web of Science ®Google Scholar
• Finegan E, Shing SLH, Chipika RH, et al. Extra-motor cerebral changes and manifestations in primary lateral sclerosis. Brain Imaging Behav. 2021;15(5):2283–2296. doi: 10.1007/s11682-020-00421-4
   PubMed Web of Science ®Google Scholar
• Agarwal S, Highton-Williamson E, Caga J, et al. Primary lateral sclerosis and the amyotrophic lateral sclerosis–frontotemporal dementia spectrum. J Neurol. 2018;265(8):1819–1828. doi: 10.1007/s00415-018-8917-5
   PubMed Web of Science ®Google Scholar
• de Vries BS, Rustemeijer LMM, Bakker LA, et al. Cognitive and behavioural changes in PLS and PMA: challenging the concept of restricted phenotypes. J Neurol Neurosurg Psychiatry. 2019;90:141–147. doi: 10.1136/jnnp-2018-318788
   PubMed Web of Science ®Google Scholar
• Mabuchi N, Watanabe H, Atsuta N, et al. Primary lateral sclerosis presenting parkinsonian symptoms without nigrostriatal involvement. J Neurol Neurosurg Psychiatry. 2004;75(12):1768–1771. doi: 10.1136/jnnp.2003.035212
   PubMed Web of Science ®Google Scholar
• Nagao S, Yokota O, Nanba R, et al. Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia. J Neurol Sci. 2012 Dec 15;323(1–2):147–153. doi: 10.1016/j.jns.2012.09.005
   PubMed Web of Science ®Google Scholar
• Liu AJ, Chang JE, Naasan G, et al. Progressive supranuclear palsy and primary lateral sclerosis secondary to globular glial tauopathy: a case report and a practical theoretical framework for the clinical prediction of this rare pathological entity. Neurocase. 2020 Mar 3;26(2):91–97. doi: 10.1080/13554794.2020.1732427
   PubMed Web of Science ®Google Scholar
• Fujita K, Matsubara T, Miyamoto R. et al. Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report. BMC neurol. 2019 Dec;19(1):1–8.
   PubMedGoogle Scholar
• Stark FM, Moersch FP. Primary lateral sclerosis: a distinct clinical entity. J Nerv Ment Dis. 1945 Oct 1;102(4):332–337. doi: 10.1097/00005053-194510000-00002
   Web of Science ®Google Scholar
• Pringle CE, Hudson AJ, Munoz DG, et al. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain. 1992;115(Pt 2):495–520. doi: 10.1093/brain/115.2.495
   PubMedGoogle Scholar
• de Carvalho M, Dengler R, Eisen A, et al. Electrodiagnostic criteria for diagnosis of als. Clin Neurophysiol. 2008;119(3):497–503. doi: 10.1016/j.clinph.2007.09.143
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Barkhaus PE, Nandedkar SD, et al. Motor unit number estimation (mune): where are we now? Clin Neurophysiol. 2018;129(8):1507–1516. doi: 10.1016/j.clinph.2018.04.748
   PubMed Web of Science ®Google Scholar
• Kuipers-Upmeijer J, de Jager AE, Hew JM, et al. Primary lateral sclerosis: clinical, neurophysiological, and magnetic resonance findings. J Neurol Neurosurg Psychiatry. 2001;71(5):615–620. doi: 10.1136/jnnp.71.5.615
   PubMed Web of Science ®Google Scholar
• Mitsumoto H, Nagy PL, Gennings C, et al. Phenotypic and molecular analyses of primary lateral sclerosis. Neurol Genet. 2015;1(1):e3. doi: 10.1212/01.NXG.0000464294.88607.dd
   PubMed Web of Science ®Google Scholar
• Fournier CN, Murphy A, Loci L, et al. Primary lateral sclerosis and early upper motor neuron disease: characteristics of a cross-sectional population. J Clin Neuromuscul Dis. 2016;17(3):99–105. doi: 10.1097/CND.0000000000000102
   PubMedGoogle Scholar
• Silva CS, Santos MO, Gromicho M, et al. Electromyographic findings in primary lateral sclerosis during disease progression. Clin Neurophysiol. 2021;132(12):2996–3001. doi: 10.1016/j.clinph.2021.08.022
   PubMed Web of Science ®Google Scholar
• Brown WF, Ebers GC, Hudson AJ, et al. Motor-evoked responses in primary lateral sclerosis. Muscle Nerve. 1992;15(5):626–629. doi: 10.1002/mus.880150515
   PubMed Web of Science ®Google Scholar
• Salerno A, Carlander B, Camu W, et al. Motor evoked potentials (meps): evaluation of the different types of responses in amyotrophic lateral sclerosis and primary lateral sclerosis. Electromyogr Clin Neurophysiol. 1996;36(6):361–368.
   PubMedGoogle Scholar
• de Carvalho M, Kiernan MC, Pullman SL, et al. Neurophysiological features of primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2020 Nov 2;21(sup1):11–17. doi: 10.1080/21678421.2020.1837174
   PubMedGoogle Scholar
• Caramia MD, Cicinelli P, Paradiso C, et al. ‘Excitability’ changes of muscular responses to magnetic brain stimulation in patients with central motor disorders. Electroencephalogr Clin Neurophysiol. 1991;81(4):243–250. doi: 10.1016/0168-5597(91)90009-M
   PubMedGoogle Scholar
• Geevasinga N, Menon P, Sue CM, et al. Cortical excitability changes distinguish the motor neuron disease phenotypes from hereditary spastic paraplegia. Eur J Neurol. 2015;22(5):826-831, e857–828. doi: 10.1111/ene.12669
   Web of Science ®Google Scholar
• Menon P, Geevasinga N, Yiannikas C, et al. Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study. Lancet Neurol. 2015;14(5):478–484. doi: 10.1016/S1474-4422(15)00014-9
   PubMed Web of Science ®Google Scholar
• Floeter MK, Mills R. Progression in primary lateral sclerosis: a prospective analysis. Amyotroph Lateral Scler. 2009 Oct;10(5–6):339–346. doi: 10.3109/17482960903171136
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Turkman A, Swash M. Motor unit firing in amyotrophic lateral sclerosis and other upper and lower motor neurone disorders. Clin Neurophysiol. 2012 Nov 1;123(11):2312–2318. doi: 10.1016/j.clinph.2012.04.016
   PubMed Web of Science ®Google Scholar
• Floeter MK, Zhai P, Saigal R. et al. Motor neuron firing dysfunction in spastic patients with primary lateral sclerosis. J Neurophysiol. 2005 Aug;94(2):919–927.
   PubMed Web of Science ®Google Scholar
• Fisher KM, Zaaimi B, Williams TL, et al. Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease. Brain. 2012 Sep 1;135(9):2849–2864. doi: 10.1093/brain/aws150
   PubMedGoogle Scholar
• Castro J, Swash M, de Carvalho M. The cutaneous silent period in motor neuron disease. Clin Neurophysiol. 2021 Feb 1;132(2):660–665. doi: 10.1016/j.clinph.2020.10.033
   PubMed Web of Science ®Google Scholar
• Brugman F, Wokke JH, Vianney de Jong JM, et al. Primary lateral sclerosis as a phenotypic manifestation of familial ALS. Neurology. 2005;64:1778–1779. doi: 10.1212/01.WNL.0000162033.47893.F7
   PubMed Web of Science ®Google Scholar
• Dupre N, Valdmanis PN, Bouchard JP, et al. Autosomal dominant primary lateral sclerosis. Neurology. 2007;68(14):1156–1157. doi: 10.1212/01.wnl.0000258678.58808.86
   PubMed Web of Science ®Google Scholar
• Praline J, Guennoc AM, Vourc’h P, et al. Primary lateral sclerosis may occur within familial amyotrophic lateral sclerosis pedigrees. Amyotroph Lateral Scler. 2010;11(1–2):154–156. doi: 10.3109/17482960802483038
   PubMed Web of Science ®Google Scholar
• Corcia P, Lunetta C, Couratier P, et al. Familial clustering of primary lateral sclerosis and amyotrophic lateral sclerosis: supplementary evidence for a continuum. Eur J Neurol. 2021 Aug;28(8):2780–2783. doi: 10.1111/ene.14960.
   PubMed Web of Science ®Google Scholar
• Gellera C, Tiloca C, Del Bo R, et al. Ubiquilin 2 mutations in italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2013;84(2):183–187. doi: 10.1136/jnnp-2012-303433
   PubMed Web of Science ®Google Scholar
• van Rheenen W, van Blitterswijk M, Huisman MH, et al. Hexanucleotide repeat expansions in c9orf72 in the spectrum of motor neuron diseases. Neurology. 2012;79(9):878–882. doi: 10.1212/WNL.0b013e3182661d14
   PubMed Web of Science ®Google Scholar
• de Boer EMJ, de Vries BS, Pennings M, et al. Genetic characterization of primary lateral sclerosis. J Neurol. 2023;270:3970–3980.
   PubMedGoogle Scholar
• Chow CY, Landers JE, Bergren SK, et al. Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with als. Am J Hum Genet. 2009;84(1):85–88. doi: 10.1016/j.ajhg.2008.12.010
   PubMed Web of Science ®Google Scholar
• Del Bo R, Tiloca C, Pensato V, et al. Novel optineurin mutations in patients with familial and sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:1239–1243. doi: 10.1136/jnnp.2011.242313
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang L, Lynch DR, et al. Compound heterozygote mutations in SPG7 in a family with adult-onset primary lateral sclerosis. Neurol Genet. 2016;2(2):e60. doi: 10.1212/NXG.0000000000000060
   PubMedGoogle Scholar
• Roeben B, Wilke C, Bender B, et al. The motor band sign in ALS: presentations and frequencies in a consecutive series of ALS patients. J Neurol Sci. 2019 Nov 15;406:116440. doi: 10.1016/j.jns.2019.116440
   PubMed Web of Science ®Google Scholar
• Kwan JY, Meoded A, Danielian LE, et al. Structural imaging differences and longitudinal changes in primary lateral sclerosis and amyotrophic lateral sclerosis. NeuroImage Clin. 2012 Dec 24;2:151–60. doi: 10.1016/j.nicl.2012.12.003
   PubMed Web of Science ®Google Scholar
• Claassen DO, Josephs KA, Peller PJ. The stripe of primary lateral sclerosis: focal primary motor cortex hypometabolism seen on fluorodeoxyglucose f18 positron emission tomography. Arch Neurol. 2010;67(1):122–125. doi: 10.1001/archneurol.2009.298
   PubMedGoogle Scholar
• van der Graaff MM, Lavini C, Akkerman EM, et al. MR spectroscopy findings in early stages of motor neuron disease. AJNR Am J Neuroradiol. 2010;31:1799–1806. doi: 10.3174/ajnr.A2217
   PubMed Web of Science ®Google Scholar
• Finegan E, Li Hi Shing S, Chipika RH, et al. Widespread subcortical grey matter degeneration in primary lateral sclerosis: a multimodal imaging study with genetic profiling. NeuroImage Clin. 2019;24:102089. doi: 10.1016/j.nicl.2019.102089
   PubMed Web of Science ®Google Scholar
• Finegan E, Hi Shing SL, Chipika RH, et al. Thalamic, hippocampal and basal ganglia pathology in primary lateral sclerosis and amyotrophic lateral sclerosis: Evidence from quantitative imaging data. Data Brief. 2020;29:105115. doi: 10.1016/j.dib.2020.105115
   PubMed Web of Science ®Google Scholar
• Tu S, Menke RAL, Talbot K, et al. Cerebellar tract alterations in PLS and ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(3–4):281–284. doi: 10.1080/21678421.2018.1562554
   PubMed Web of Science ®Google Scholar
• Iwata NK, Kwan JY, Danielian LE, et al. White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis. Brain. 2011 Sep 1;134(9):2642–2655. doi: 10.1093/brain/awr178
   PubMedGoogle Scholar
• Steinacker P, Feneberg E, Weishaupt J, et al. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J Neurol Neurosurg Psychiatry. 2016;87:12–20. doi: 10.1136/jnnp-2015-311387
   PubMed Web of Science ®Google Scholar
• Verde F, Zaina G, Bodio C, et al. Cerebrospinal fluid phosphorylated neurofilament heavy chain and chitotriosidase in primary lateral sclerosis. J Neurol Neurosurg Psychiatry. 2021;92(2):221–223. doi: 10.1136/jnnp-2020-324059
   PubMed Web of Science ®Google Scholar
• Thompson AG, Gray E, Bampton A, et al. CSF chitinase proteins in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90(11):1215–1220. doi: 10.1136/jnnp-2019-320442
   PubMed Web of Science ®Google Scholar
• Thompson AG, Gray E, Thezenas ML, et al. Cerebrospinal fluid macrophage biomarkers in amyotrophic lateral sclerosis. Ann Neurol. 2018;83(2):258–268. doi: 10.1002/ana.25143
   PubMed Web of Science ®Google Scholar
• Schito P, Russo T, Domi T, et al. Clinical features and biomarkers to differentiate primary and amyotrophic lateral sclerosis in patients with an upper motor neuron syndrome. Neurology. 2023 Aug 22;101(8):352–356. doi: 10.1212/WNL.0000000000207223
   PubMed Web of Science ®Google Scholar
• Lee I, Stingone JA, Chan RB, et al. Utilizing machine learning and lipidomics to distinguish primary lateral sclerosis from amyotrophic lateral sclerosis. Muscle Nerve. 2023;67(4):306–310. doi: 10.1002/mus.27797
   PubMed Web of Science ®Google Scholar
• Becker A, Hardmeier M, Steck AJ, et al. Primary lateral sclerosis presenting with isolated progressive pseudobulbar syndrome. Eur J Neurol. 2007;14(8):e3. doi: 10.1111/j.1468-1331.2007.01699.x
   PubMed Web of Science ®Google Scholar
• Schule R, Wiethoff S, Martus P, et al. Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients. Ann Neurol. 2016;79(4):646–658. doi: 10.1002/ana.24611
   PubMed Web of Science ®Google Scholar
• Costa MR, Gromicho M, Pronto-Laborinho AC, et al. Novel TBK1 LoF variant in a family with upper motor neuron predominant motor neuron disease. J Neurol Sci. 2019 Aug 15;403:117–118. doi: 10.1016/j.jns.2019.06.029
   PubMed Web of Science ®Google Scholar
• Chio A, Mazzini L, Mora G. Disease-modifying therapies in amyotrophic lateral sclerosis. Neuropharmacology. 2020;167:107986. doi: 10.1016/j.neuropharm.2020.107986
   PubMed Web of Science ®Google Scholar
• Hassan AB, Salihu AT, Masta MA, et al. Effect of transcutaneous spinal direct current stimulation on spasticity in upper motor neuron conditions: a systematic review and meta-analysis. Spinal Cord. 2023;28(11):1–3. doi: 10.1038/s41393-023-00928-9
   Google Scholar
• Pioro EP. Review of dextromethorphan 20 mg/quinidine 10 mg (NUEDEXTA®) for pseudobulbar affect. Neurol Ther. 2014;3(1):15–28. doi: 10.1007/s40120-014-0018-5
   PubMedGoogle Scholar
• Costa J, Rocha ML, Ferreira J. et al. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis. J Neurol. 2008 Apr;255(4):545–550.
   PubMed Web of Science ®Google Scholar
• James E, Ellis C, Brassington R, et al. Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis. Cochrane Database of Systematic Reviews. 2022;5(5):CD006981. doi: 10.1002/14651858.CD006981.pub3
   PubMedGoogle Scholar
• Mitsumoto H, Chiuzan C, Gilmore M. et al. Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale. Muscle Nerve. 2020 Feb;61(2):163–172.
   PubMed Web of Science ®Google Scholar
• Hassan A, Mittal SO, Hu WT. et al. Does limited EMG denervation in early primary lateral sclerosis predict amyotrophic lateral sclerosis? Amyotroph Lateral Scler Frontotemporal Degener. 2022 Nov;23(7–8):554–561.
   PubMed Web of Science ®Google Scholar
• Bista S, Coffey A, Fasano A, et al. Cortico-muscular coherence in primary lateral sclerosis reveals abnormal cortical engagement during motor function beyond primary motor areas. Cereb Cortex. 2023 May 4;33(13):8712–8723. doi: 10.1093/cercor/bhad152
   PubMed Web of Science ®Google Scholar
• Gouveia RG, Pinto A, Evangelista T, et al. Evidence for central abnormality in respiratory control in primary lateral sclerosis. Amyotroph Lateral Scler. 2006 Jan 1;7(1):57–60. doi: 10.1080/14660820510012031
   PubMedGoogle Scholar
• De Carvalho M, Costa J, Pinto S, et al. Percutaneous nocturnal oximetry in amyotrophic lateral sclerosis: periodic desaturation. Amyotroph Lateral Scler. 2009 Jan 1;10(3):154–161. doi: 10.1080/17482960802382305
   PubMedGoogle Scholar